ijms-logo

Journal Browser

Journal Browser

Theme Issue Honoring Prof. Dr. Ludger Wessjohann’s 60th Birthday: Natural Products in Modern Drug Discovery

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 53127

Printed Edition Available!
A printed edition of this Special Issue is available here.

Special Issue Editor

Special Issue Information

Dear Colleagues,

In 2021, Prof. Dr. Ludger Wessjohann, Professor and Director of Department Bioorganic Chemistry at Leibniz Institute of Plant Biochemistry, Halle, Germany has his 60th birthday. In recognition of his outstanding lifetime scientific contribution, we have arranged a Special Issue to which you are invited to submit a manuscript.

Prof. Dr Ludger A. Wessjohann

Director Dept. Bioorganic Chemistry

& Full Professor of Chemistry

Leibniz Institute of Plant Biochemistry (IPB)

Address: Weinberg 3, 06120 Halle (Saale), Germany

E-mail: wessjohann@ipb-halle.de

http://www.ipb-halle.de/en/research/bioorganic-chemistry/

Orcid: 0000-0003-2060-8235

Professor Wessjohann studied chemistry in Hamburg (Germany), Southampton (UK), and Oslo (Norway, Prof. Skattebøl). He earned his doctorate in 1990 with Prof. de Meijere in Hamburg. After a short period as lecturer in Brazil, he became a postdoctoral Feodor-Lynen fellow of the Alexander von Humboldt-foundation with Prof. Paul Wender at Stanford University (USA) working on the total synthesis of Taxol®. After an assistant professorship in Munich (LMU, 1992-1998), he was appointed to the Chair of Bioorganic Chemistry at the Vrije Universiteit Amsterdam (NL), working on organometallic chemistry and biocatalysis. Since 2001, he is director of the dept. of bioorganic chemistry at the Leibniz Institute of Plant Biochemistry (IPB) in Halle (Germany), and in parallel holds the chair of natural product chemistry of the Martin Luther-University Halle-Wittenberg. From 2010-2017 he served as the Managing Director of the IPB (www.ipb-halle.de).

Prof. Wessjohann focuses on the discovery, synthesis and application of natural products and bioactive derivatives thereof. He has over 400 publications, 30 patent applications, and is co-founder of six companies. He is member of many boards and commissions, including recently the “mision de sabios” of the Colombian government. He received numerous scholarships, prizes and honors, e.g. Microsoft IT Founders Award, and is a foreign member of the Brazilian Academy of Science.

Natural products (NPs) and their derivatives have historically made a major contribution to pharmacotherapy, in particular for cancer and infectious diseases. NPs are characterized by intriguing scaffold diversity along with structural complexity and because of this NPs continue to be an crucial source of leads for new medicines. Cancer is a world health issue and affects all communities around the globe regardless of religion, race or age. It is noteworthy that cancer is the second leading cause of death globally and is responsible for around 9.6 million deaths in 2018. Natural products (NPs) represent a tremendous resource for anticancer drug development along with treatment of other human diseases. Notably, about 80% of cancer therapy drugs approved by the United States Food and Drug Administration (FDA) during the last three decades are either NPs, NP derivatives, or mimicked NPs. Moreover 41% (646/1562) of all new drug approvals between 1981 and 2014 are NPs or derived from NPs. This illustrates that there is still an urgent need for the development of novel anti-cancer drugs with a unique mechanism of action. 

This Special Issue welcomes original articles, communications and reviews dealing with the isolation and/or the investigation of mechanisms of action of natural products and their synthetic analogs with potential anti-cancer effects. In addition, this Special Issue also welcomes articles about the role of natural products and their derivatives to treat infectious diseases, microbial diseases, cardiovascular diseases and other human diseases. Finding target-identification (with biological assays together with computational studies), in vivo studies and the design of novel natural product derivatives with improved biological effects are also welcome.


text

Prof. Dr. Hidayat Hussain
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Drug Discovery
  • Natural products
  • Natural product derivatives
  • Cancer
  • Infectious diseases
  • Microbial diseases
  • Diabetes
  • Cardiovascular diseases
  • Human health
  • Human diseases
  • Computational methods
  • In vitro studies
  • In vivo studies
  • Mechanism of action

Published Papers (18 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

5 pages, 214 KiB  
Editorial
Editorial to Special Issue “Theme Issue Honoring Prof. Dr. Ludger Wessjohann’s 60th Birthday: Natural Products in Modern Drug Discovery”
by Hidayat Hussain
Int. J. Mol. Sci. 2022, 23(10), 5835; https://doi.org/10.3390/ijms23105835 - 23 May 2022
Viewed by 978
Abstract
Nature continuously produces biologically useful molecules and provides mankind with life-saving drugs or therapies [...] Full article
6 pages, 696 KiB  
Editorial
Prof. Ludger Wessjohann: A Lifelong Career Dedicated to a Remarkable Service in “Natural Products Sciences”
by Hidayat Hussain
Int. J. Mol. Sci. 2022, 23(10), 5440; https://doi.org/10.3390/ijms23105440 - 13 May 2022
Viewed by 1926
Abstract
It is a great honor and a pleasure for me to serve as Guest Editor for this Issue of the “International Journal of Molecular Sciences”, dedicated to our mentor and colleague, Professor Dr [...] Full article
Show Figures

Figure 1

Research

Jump to: Editorial, Review

18 pages, 5629 KiB  
Article
Synthesis of Multiple Bispecific Antibody Formats with Only One Single Enzyme Based on Enhanced Trypsiligase
by Johanna Voigt, Christoph Meyer and Frank Bordusa
Int. J. Mol. Sci. 2022, 23(6), 3144; https://doi.org/10.3390/ijms23063144 - 15 Mar 2022
Cited by 2 | Viewed by 1926
Abstract
Bispecific antibodies (bsAbs) were first developed in the 1960s and are now emerging as a leading class of immunotherapies for cancer treatment with the potential to further improve clinical efficacy and safety. Many different formats of bsAbs have been established in the last [...] Read more.
Bispecific antibodies (bsAbs) were first developed in the 1960s and are now emerging as a leading class of immunotherapies for cancer treatment with the potential to further improve clinical efficacy and safety. Many different formats of bsAbs have been established in the last few years, mainly generated genetically. Here we report on a novel, flexible, and fast chemo–enzymatic, as well as purely enzymatic strategies, for generating bispecific antibody fragments by covalent fusion of two functional antibody Fab fragments (Fabs). For the chemo–enzymatic approach, we first modified the single Fabs site-specifically with click anchors using an enhanced Trypsiligase variant (eTl) and afterward converted the modified Fabs into the final heterodimers via click chemistry. Regarding the latter, we used the strain-promoted alkyne-azide cycloaddition (SPAAC) and inverse electron-demand Diels–Alder reaction (IEDDA) click approaches well known for their fast reaction kinetics and fewer side reactions. For applications where the non-natural linkages or hydrophobic click chemistry products might interfere, we developed two purely enzymatic alternatives enabling C- to C- and C- to N-terminal coupling of the two Fabs via a native peptide bond. This simple system could be expanded into a modular system, eliminating the need for extensive genetic engineering. The bispecific Fab fragments (bsFabs) produced here to bind the growth factors ErbB2 and ErbB3 with similar KD values, such as the sole Fabs. Tested in breast cancer cell lines, we obtained biologically active bsFabs with improved properties compared to its single Fab counterparts. Full article
Show Figures

Figure 1

19 pages, 2626 KiB  
Article
Induction of Isochromanones by Co-Cultivation of the Marine Fungus Cosmospora sp. and the Phytopathogen Magnaporthe oryzae
by Ernest Oppong-Danquah, Martina Blümel, Silvia Scarpato, Alfonso Mangoni and Deniz Tasdemir
Int. J. Mol. Sci. 2022, 23(2), 782; https://doi.org/10.3390/ijms23020782 - 11 Jan 2022
Cited by 9 | Viewed by 2305
Abstract
Microbial co-cultivation is a promising approach for the activation of biosynthetic gene clusters (BGCs) that remain transcriptionally silent under artificial culture conditions. As part of our project aiming at the discovery of marine-derived fungal agrochemicals, we previously used four phytopathogens as model competitors [...] Read more.
Microbial co-cultivation is a promising approach for the activation of biosynthetic gene clusters (BGCs) that remain transcriptionally silent under artificial culture conditions. As part of our project aiming at the discovery of marine-derived fungal agrochemicals, we previously used four phytopathogens as model competitors in the co-cultivation of 21 marine fungal strains. Based on comparative untargeted metabolomics analyses and anti-phytopathogenic activities of the co-cultures, we selected the co-culture of marine Cosmospora sp. with the phytopathogen Magnaporthe oryzae for in-depth chemical studies. UPLC-MS/MS-based molecular networking (MN) of the co-culture extract revealed an enhanced diversity of compounds in several molecular families, including isochromanones, specifically induced in the co-culture. Large scale co-cultivation of Cosmospora sp. and M. oryzae resulted in the isolation of five isochromanones from the whole co-culture extract, namely the known soudanones A, E, D (1-3) and their two new derivatives, soudanones H-I (4-5), the known isochromans, pseudoanguillosporins A and B (6, 7), naphtho-γ-pyrones, cephalochromin and ustilaginoidin G (8, 9), and ergosterol (10). Their structures were established by NMR, HR-ESIMS, FT-IR, electronic circular dichroism (ECD) spectroscopy, polarimetry ([α]D), and Mosher’s ester reaction. Bioactivity assays revealed antimicrobial activity of compounds 2 and 3 against the phytopathogens M. oryzae and Phytophthora infestans, while pseudoanguillosporin A (6) showed the broadest and strongest anti-phytopathogenic activity against Pseudomonas syringae, Xanthomonas campestris, M. oryzae and P. infestans. This is the first study assessing the anti-phytopathogenic activities of soudanones. Full article
Show Figures

Figure 1

18 pages, 5210 KiB  
Article
Butein and Frondoside-A Combination Exhibits Additive Anti-Cancer Effects on Tumor Cell Viability, Colony Growth, and Invasion and Synergism on Endothelial Cell Migration
by Shahrazad Sulaiman, Kholoud Arafat, Aya Mudhafar Al-Azawi, Noura Abdulraouf AlMarzooqi, Shamsa Nasser Ali Hussain Lootah and Samir Attoub
Int. J. Mol. Sci. 2022, 23(1), 431; https://doi.org/10.3390/ijms23010431 - 31 Dec 2021
Cited by 11 | Viewed by 2127
Abstract
Despite the significant advances in targeted- and immuno-therapies, lung and breast cancer are at the top list of cancer incidence and mortality worldwide as of 2020. Combination therapy consisting of a mixture of different drugs taken at once is currently the main approach [...] Read more.
Despite the significant advances in targeted- and immuno-therapies, lung and breast cancer are at the top list of cancer incidence and mortality worldwide as of 2020. Combination therapy consisting of a mixture of different drugs taken at once is currently the main approach in cancer management. Natural compounds are extensively investigated for their promising anti-cancer potential. This study explored the anti-cancer potential of butein, a biologically active flavonoid, on two major solid tumors, namely, A549 lung and MDA-MB-231 breast cancer cells alone and in combination with another natural anti-cancer compound, frondoside-A. We demonstrated that butein decreases A549 and MDA-MB-231 cancer cell viability and colony growth in vitro in addition to tumor growth on chick embryo chorioallantoic membrane (CAM) in vivo without inducing any noticeable toxicity. Additionally, non-toxic concentrations of butein significantly reduced the migration and invasion of both cell lines, suggesting its potential anti-metastatic effect. We showed that butein anti-cancer effects are due, at least in part, to a potent inhibition of STAT3 phosphorylation, leading to PARP cleavage and consequently cell death. Moreover, we demonstrated that combining butein with frondoside-A leads to additive effects on inhibiting A549 and MDA-MB-231 cellular viability, induction of caspase 3/7 activity, inhibition of colony growth, and inhibition of cellular migration and invasion. This combination reached a synergistic effect on the inhibition of HUVECs migration in vitro. Collectively, this study provides sufficient rationale to further carry out animal studies to confirm the relevance of these compounds’ combination in cancer therapy. Full article
Show Figures

Figure 1

13 pages, 4948 KiB  
Article
Target Characterization of Kaempferol against Myocardial Infarction Using Novel In Silico Docking and DARTS Prediction Strategy
by Xunxun Wu, Xiaokun Li, Chunxue Yang and Yong Diao
Int. J. Mol. Sci. 2021, 22(23), 12908; https://doi.org/10.3390/ijms222312908 - 29 Nov 2021
Cited by 4 | Viewed by 2029
Abstract
Target identification is a crucial process for advancing natural products and drug leads development, which is often the most challenging and time-consuming step. However, the putative biological targets of natural products obtained from traditional prediction studies are also informatively redundant. Thus, how to [...] Read more.
Target identification is a crucial process for advancing natural products and drug leads development, which is often the most challenging and time-consuming step. However, the putative biological targets of natural products obtained from traditional prediction studies are also informatively redundant. Thus, how to precisely identify the target of natural products is still one of the major challenges. Given the shortcomings of current target identification methodologies, herein, a novel in silico docking and DARTS prediction strategy was proposed. Concretely, the possible molecular weight was detected by DARTS method through examining the protected band in SDS-PAGE. Then, the potential targets were obtained from screening and identification through the PharmMapper Server and TargetHunter method. In addition, the candidate target Src was further validated by surface plasmon resonance assay, and the anti-apoptosis effects of kaempferol against myocardial infarction were further confirmed by in vitro and in vivo assays. Collectively, these results demonstrated that the integrated strategy could efficiently characterize the targets, which may shed a new light on target identification of natural products. Full article
Show Figures

Figure 1

21 pages, 4092 KiB  
Article
Rare Glutamic Acid Methyl Ester Peptaibols from Sepedonium ampullosporum Damon KSH 534 Exhibit Promising Antifungal and Anticancer Activity
by Yen T. H. Lam, Manuel G. Ricardo, Robert Rennert, Andrej Frolov, Andrea Porzel, Wolfgang Brandt, Pauline Stark, Bernhard Westermann and Norbert Arnold
Int. J. Mol. Sci. 2021, 22(23), 12718; https://doi.org/10.3390/ijms222312718 - 24 Nov 2021
Cited by 7 | Viewed by 2759
Abstract
Fungal species of genus Sepedonium are rich sources of diverse secondary metabolites (e.g., alkaloids, peptaibols), which exhibit variable biological activities. Herein, two new peptaibols, named ampullosporin F (1) and ampullosporin G (2), together with five known compounds, ampullosporin A [...] Read more.
Fungal species of genus Sepedonium are rich sources of diverse secondary metabolites (e.g., alkaloids, peptaibols), which exhibit variable biological activities. Herein, two new peptaibols, named ampullosporin F (1) and ampullosporin G (2), together with five known compounds, ampullosporin A (3), peptaibolin (4), chrysosporide (5), c(Trp-Ser) (6) and c(Trp-Ala) (7), have been isolated from the culture of Sepedonium ampullosporum Damon strain KSH534. The structures of 1 and 2 were elucidated based on ESI-HRMSn experiments and intense 1D and 2D NMR analyses. The sequence of ampullosporin F (1) was determined to be Ac-Trp1-Ala2-Aib3-Aib4-Leu5-Aib6-Gln7-Aib8-Aib9-Aib10-GluOMe11-Leu12-Aib13-Gln14-Leuol15, while ampullosporin G (2) differs from 1 by exchanging the position of Gln7 with GluOMe11. Furthermore, the total synthesis of 1 and 2 was carried out on solid-phase to confirm the absolute configuration of all chiral amino acids as L. In addition, ampullosporin F (1) and G (2) showed significant antifungal activity against B. cinerea and P. infestans, but were inactive against S. tritici. Cell viability assays using human prostate (PC-3) and colorectal (HT-29) cancer cells confirmed potent anticancer activities of 1 and 2. Furthermore, a molecular docking study was performed in silico as an attempt to explain the structure-activity correlation of the characteristic ampullosporins (13). Full article
Show Figures

Figure 1

13 pages, 2050 KiB  
Article
COX Inhibitory and Cytotoxic Naphthoketal-Bearing Polyketides from Sparticola junci
by Katherine Yasmin M. Garcia, Mark Tristan J. Quimque, Gian Primahana, Andreas Ratzenböck, Mark Joseph B. Cano, Jeremiah Francis A. Llaguno, Hans-Martin Dahse, Chayanard Phukhamsakda, Frank Surup, Marc Stadler and Allan Patrick G. Macabeo
Int. J. Mol. Sci. 2021, 22(22), 12379; https://doi.org/10.3390/ijms222212379 - 17 Nov 2021
Cited by 5 | Viewed by 2106
Abstract
Axenic fermentation on solid rice of the saprobic fungus Sparticola junci afforded two new highly oxidized naphthalenoid polyketide derivatives, sparticatechol A (1) and sparticolin H (2) along with sparticolin A (3). The structures of 1 and 2 [...] Read more.
Axenic fermentation on solid rice of the saprobic fungus Sparticola junci afforded two new highly oxidized naphthalenoid polyketide derivatives, sparticatechol A (1) and sparticolin H (2) along with sparticolin A (3). The structures of 1 and 2 were elucidated on the basis of their NMR and HR-ESIMS spectroscopic data. Assignment of absolute configurations was performed using electronic circular dichroism (ECD) experiments and Time-Dependent Density Functional Theory (TDDFT) calculations. Compounds 1–3 were evaluated for COX inhibitory, antiproliferative, cytotoxic and antimicrobial activities. Compounds 1 and 2 exhibited strong inhibitory activities against COX-1 and COX-2. Molecular docking analysis of 1 conferred favorable binding against COX-2. Sparticolin H (2) and A (3) showed a moderate antiproliferative effect against myelogenous leukemia K-562 cells and weak cytotoxicity against HeLa and mouse fibroblast cells. Full article
Show Figures

Graphical abstract

16 pages, 7291 KiB  
Article
ATG 4B Serves a Crucial Role in RCE-4-Induced Inhibition of the Bcl-2–Beclin 1 Complex in Cervical Cancer Ca Ski Cells
by Fang-Fang You, Jing Zhang, Fan Cheng, Kun Zou, Xue-Qing Zhang and Jian-Feng Chen
Int. J. Mol. Sci. 2021, 22(22), 12302; https://doi.org/10.3390/ijms222212302 - 14 Nov 2021
Cited by 5 | Viewed by 1804
Abstract
RCE-4, a steroidal saponin isolated from Reineckia carnea, has been studied previously and has exhibited promising anti-cervical cancer properties by inducing programmed cell death (PCD) of Ca Ski cells. Considering the cancer cells developed various pathways to evade chemotherapy-induced PCD, there is, [...] Read more.
RCE-4, a steroidal saponin isolated from Reineckia carnea, has been studied previously and has exhibited promising anti-cervical cancer properties by inducing programmed cell death (PCD) of Ca Ski cells. Considering the cancer cells developed various pathways to evade chemotherapy-induced PCD, there is, therefore, an urgent need to further explore the potential mechanisms underlying its actions. The present study focused on targeting the Bcl-2–Beclin 1 complex, which is known as the key regulator of PCD, to deeply elucidate the molecular mechanism of RCE-4 against cervical cancer. The effects of RCE-4 on the Bcl-2–Beclin 1 complex were investigated by using the co-immunoprecipitation assay. In addition, autophagy-related genes (ATG) were also analyzed due to their special roles in PCD. The results demonstrated that RCE-4 inhibited the formation of the Bcl-2–Beclin 1 complex in Ca Ski cells via various pathways, and ATG 4B proteins involved in this process served as a key co-factor. Furthermore, based on the above, the sensitivity of RCE-4 to Ca Ski cells was significantly enhanced by inhibiting the expression of the ATG 4B by applying the ATG 4B siRNA plasmid. Full article
Show Figures

Figure 1

19 pages, 6121 KiB  
Article
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy
by Silke Schrom, Thomas Hebesberger, Stefanie Angela Wallner, Ines Anders, Erika Richtig, Waltraud Brandl, Birgit Hirschmugl, Mariangela Garofalo, Claudia Bernecker, Peter Schlenke, Karl Kashofer, Christian Wadsack, Ariane Aigelsreiter, Ellen Heitzer, Sabrina Riedl, Dagmar Zweytick, Nadine Kretschmer, Georg Richtig and Beate Rinner
Int. J. Mol. Sci. 2021, 22(21), 11318; https://doi.org/10.3390/ijms222111318 - 20 Oct 2021
Cited by 2 | Viewed by 2314
Abstract
Melanomas are aggressive tumors with a high metastatic potential and an increasing incidence rate. They are known for their heterogeneity and propensity to easily develop therapy-resistance. Nowadays they are one of the most common cancers diagnosed during pregnancy. Due to the difficulty in [...] Read more.
Melanomas are aggressive tumors with a high metastatic potential and an increasing incidence rate. They are known for their heterogeneity and propensity to easily develop therapy-resistance. Nowadays they are one of the most common cancers diagnosed during pregnancy. Due to the difficulty in balancing maternal needs and foetal safety, melanoma is challenging to treat. The aim of this study was to provide a potential model system for the study of melanoma in pregnancy and to illustrate melanoma heterogeneity. For this purpose, a pigmented and a non-pigmented section of a lymph node metastasis from a pregnant patient were cultured under different conditions and characterized in detail. All four culture conditions exhibited different phenotypic, genotypic as well as tumorigenic properties, and resulted in four newly established melanoma cell lines. To address treatment issues, especially in pregnant patients, the effect of synthetic human lactoferricin-derived peptides was tested successfully. These new BRAF-mutated MUG Mel3 cell lines represent a valuable model in melanoma heterogeneity and melanoma pregnancy research. Furthermore, treatment with anti-tumor peptides offers an alternative to conventionally used therapeutic options—especially during pregnancy. Full article
Show Figures

Figure 1

11 pages, 1505 KiB  
Communication
Polygodial and Ophiobolin A Analogues for Covalent Crosslinking of Anticancer Targets
by Vladimir Maslivetc, Breana Laguera, Sunena Chandra, Ramesh Dasari, Wesley J. Olivier, Jason A. Smith, Alex C. Bissember, Marco Masi, Antonio Evidente, Veronique Mathieu and Alexander Kornienko
Int. J. Mol. Sci. 2021, 22(20), 11256; https://doi.org/10.3390/ijms222011256 - 19 Oct 2021
Cited by 5 | Viewed by 2306
Abstract
In a search of small molecules active against apoptosis-resistant cancer cells, including glioma, melanoma, and non-small cell lung cancer, we previously prepared α,β- and γ,δ-unsaturated ester analogues of polygodial and ophiobolin A, compounds capable of pyrrolylation of primary amines and demonstrating double-digit micromolar [...] Read more.
In a search of small molecules active against apoptosis-resistant cancer cells, including glioma, melanoma, and non-small cell lung cancer, we previously prepared α,β- and γ,δ-unsaturated ester analogues of polygodial and ophiobolin A, compounds capable of pyrrolylation of primary amines and demonstrating double-digit micromolar antiproliferative potencies in cancer cells. In the current work, we synthesized dimeric and trimeric variants of such compounds in an effort to discover compounds that could crosslink biological primary amine containing targets. We showed that such compounds retain the pyrrolylation ability and possess enhanced single-digit micromolar potencies toward apoptosis-resistant cancer cells. Target identification studies of these interesting compounds are underway. Full article
Show Figures

Graphical abstract

11 pages, 1261 KiB  
Article
Synthesis of Demissidine Analogues from Tigogenin via Imine Intermediates
by Agnieszka Wojtkielewicz, Urszula Kiełczewska, Aneta Baj and Jacek W. Morzycki
Int. J. Mol. Sci. 2021, 22(19), 10879; https://doi.org/10.3390/ijms221910879 - 08 Oct 2021
Cited by 2 | Viewed by 1812
Abstract
A five-step transformation of a spiroketal side chain of tigogenin into an indolizidine system present in solanidane alkaloids such as demissidine and solanidine was elaborated. The key intermediate in the synthesis was spiroimine 3 readily obtained from tigogenin by its RuO4 oxidation [...] Read more.
A five-step transformation of a spiroketal side chain of tigogenin into an indolizidine system present in solanidane alkaloids such as demissidine and solanidine was elaborated. The key intermediate in the synthesis was spiroimine 3 readily obtained from tigogenin by its RuO4 oxidation to 5,6-dihydrokryptogenin followed by amination with aluminum amide generated in situ from DIBAlH and ammonium chloride. The mild reduction of spiroimine to a 26-hydroxy-dihydropyrrole derivative and subsequent mesylation resulted in the formation of 25-epidemissidinium salt or 23-sulfone depending on reaction conditions. Full article
Show Figures

Figure 1

14 pages, 2343 KiB  
Article
The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro
by Yu Jin Kim, Nayeong Yuk, Hee Jeong Shin and Hye Jin Jung
Int. J. Mol. Sci. 2021, 22(19), 10731; https://doi.org/10.3390/ijms221910731 - 03 Oct 2021
Cited by 12 | Viewed by 3294
Abstract
Hepatocellular carcinoma (HCC) is a malignant type of primary liver cancer with high incidence and mortality, worldwide. A major challenge in the treatment of HCC is chemotherapeutic resistance. It is therefore necessary to develop novel anticancer drugs for suppressing the growth of HCC [...] Read more.
Hepatocellular carcinoma (HCC) is a malignant type of primary liver cancer with high incidence and mortality, worldwide. A major challenge in the treatment of HCC is chemotherapeutic resistance. It is therefore necessary to develop novel anticancer drugs for suppressing the growth of HCC cells and overcoming drug resistance for improving the treatment of HCC. Violacein is a deep violet-colored indole derivative that is produced by several bacterial strains, including Chromobacterium violaceum, and it possesses numerous pharmacological properties, including antitumor activity. However, the therapeutic effects of violacein and the mechanism underlying its antitumor effect against HCC remain to be elucidated. This study is the first to demonstrate that violacein inhibits the proliferation and stemness of Huh7 and Hep3B HCC cells. The antiproliferative effect of violacein was attributed to cell cycle arrest at the sub-G1 phase and the induction of apoptotic cell death. Violacein induced nuclear condensation, dissipated mitochondrial membrane potential (MMP), increased generation of reactive oxygen species (ROS), activated the caspase cascade, and upregulated p53 and p21. The anticancer effect of violacein on HCC cells was also associated with the downregulation of protein kinase B (AKT) and extracellular signal-regulated kinase (ERK)1/2 signaling. Violacein not only suppressed the proliferation and formation of tumorspheres of Huh7 and Hep3B cancer stem-like cells but also reduced the expression of key markers of cancer stemness, including CD133, Sox2, Oct4, and Nanog, by inhibiting the signal transducer and activator of transcription 3 (STAT3)/AKT/ERK pathways. These results suggest the therapeutic potential of violacein in effectively suppressing HCC by targeting the proliferation and stemness of HCC cells. Full article
Show Figures

Figure 1

13 pages, 1783 KiB  
Article
Incomptine A Induces Apoptosis, ROS Production and a Differential Protein Expression on Non-Hodgkin’s Lymphoma Cells
by Emmanuel Pina-Jiménez, Fernando Calzada, Elihú Bautista, Rosa María Ordoñez-Razo, Claudia Velázquez, Elizabeth Barbosa and Normand García-Hernández
Int. J. Mol. Sci. 2021, 22(19), 10516; https://doi.org/10.3390/ijms221910516 - 29 Sep 2021
Cited by 10 | Viewed by 2042
Abstract
Sesquiterpene lactones are of pharmaceutical interest due their cytotoxic and antitumor properties, which are commonly found within plants of several genera from the Asteraceae family such as the Decachaeta genus. From Decachaeta incompta four heliangolide, namely incomptines A-D have been isolated. In this [...] Read more.
Sesquiterpene lactones are of pharmaceutical interest due their cytotoxic and antitumor properties, which are commonly found within plants of several genera from the Asteraceae family such as the Decachaeta genus. From Decachaeta incompta four heliangolide, namely incomptines A-D have been isolated. In this study, cytotoxic properties of incomptine A (IA) were evaluated on four lymphoma cancer cell lines: U-937, Farage, SU-DHL-2, and REC-1. The type of cell death induced by IA and its effects on U-937 cells were analyzed based on its capability to induce apoptosis and produce reactive oxygen species (ROS) through flow cytometry with 4′,6-diamidino-2-phenylindole staining, dual annexin V/DAPI staining, and dichlorofluorescein 2′,7′-diacetate, respectively. A differential protein expression analysis study was carried out by isobaric tags for relative and absolute quantitation (iTRAQ) through UPLC-MS/MS. Results reveal that IA exhibited cytotoxic activity against the cell line U-937 (CC50 of 0.12 ± 0.02 μM) and the incubation of these cells in presence of IA significantly increased apoptotic population and intracellular ROS levels. In the proteomic approach 1548 proteins were differentially expressed, out of which 587 exhibited a fold-change ≥ 1.5 and 961 a fold-change ≤ 0.67. Most of these differentially regulated proteins are involved in apoptosis, oxidative stress, glycolytic metabolism, or cytoskeleton structuration. Full article
Show Figures

Figure 1

18 pages, 5028 KiB  
Article
Access to New Cytotoxic Triterpene and Steroidal Acid-TEMPO Conjugates by Ugi Multicomponent-Reactions
by Haider N. Sultani, Ibrahim Morgan, Hidayat Hussain, Andreas H. Roos, Haleh H. Haeri, Goran N. Kaluđerović, Dariush Hinderberger and Bernhard Westermann
Int. J. Mol. Sci. 2021, 22(13), 7125; https://doi.org/10.3390/ijms22137125 - 01 Jul 2021
Cited by 11 | Viewed by 3187
Abstract
Multicomponent reactions, especially the Ugi-four component reaction (U-4CR), provide powerful protocols to efficiently access compounds having potent biological and pharmacological effects. Thus, a diverse library of betulinic acid (BA), fusidic acid (FA), cholic acid (CA) conjugates with TEMPO (nitroxide) have been prepared using [...] Read more.
Multicomponent reactions, especially the Ugi-four component reaction (U-4CR), provide powerful protocols to efficiently access compounds having potent biological and pharmacological effects. Thus, a diverse library of betulinic acid (BA), fusidic acid (FA), cholic acid (CA) conjugates with TEMPO (nitroxide) have been prepared using this approach, which also makes them applicable in electron paramagnetic resonance (EPR) spectroscopy. Moreover, convertible amide modified spin-labelled fusidic acid derivatives were selected for post-Ugi modification utilizing a wide range of reaction conditions which kept the paramagnetic center intact. The nitroxide labelled betulinic acid analogue 6 possesses cytotoxic effects towards two investigated cell lines: prostate cancer PC3 (IC50 7.4 ± 0.7 μM) and colon cancer HT29 (IC50 9.0 ± 0.4 μM). Notably, spin-labelled fusidic acid derivative 8 acts strongly against these two cancer cell lines (PC3: IC50 6.0 ± 1.1 μM; HT29: IC50 7.4 ± 0.6 μM). Additionally, another fusidic acid analogue 9 was also found to be active towards HT29 with IC50 7.0 ± 0.3 μM (CV). Studies on the mode of action revealed that compound 8 increased the level of caspase-3 significantly which clearly indicates induction of apoptosis by activation of the caspase pathway. Furthermore, the exclusive mitochondria targeting of compound 18 was successfully achieved, since mitochondria are the major source of ROS generation. Full article
Show Figures

Graphical abstract

Review

Jump to: Editorial, Research

49 pages, 4034 KiB  
Review
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
by Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, Hossein Saleki, Mohammad Amin Khoshbakht, Sina Sabet, Mohamad Javad Naghdi, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Sepideh Mirzaei, Ali Zarrabi and Gautam Sethi
Int. J. Mol. Sci. 2021, 22(21), 11669; https://doi.org/10.3390/ijms222111669 - 28 Oct 2021
Cited by 27 | Viewed by 4261
Abstract
As a multifactorial disease, treatment of cancer depends on understanding unique mechanisms involved in its progression. The cancer stem cells (CSCs) are responsible for tumor stemness and by enhancing colony formation, proliferation as well as metastasis, and these cells can also mediate resistance [...] Read more.
As a multifactorial disease, treatment of cancer depends on understanding unique mechanisms involved in its progression. The cancer stem cells (CSCs) are responsible for tumor stemness and by enhancing colony formation, proliferation as well as metastasis, and these cells can also mediate resistance to therapy. Furthermore, the presence of CSCs leads to cancer recurrence and therefore their complete eradication can have immense therapeutic benefits. The present review focuses on targeting CSCs by natural products in cancer therapy. The growth and colony formation capacities of CSCs have been reported can be attenuated by the dietary agents. These compounds can induce apoptosis in CSCs and reduce tumor migration and invasion via EMT inhibition. A variety of molecular pathways including STAT3, Wnt/β-catenin, Sonic Hedgehog, Gli1 and NF-κB undergo down-regulation by dietary agents in suppressing CSC features. Upon exposure to natural agents, a significant decrease occurs in levels of CSC markers including CD44, CD133, ALDH1, Oct4 and Nanog to impair cancer stemness. Furthermore, CSC suppression by dietary agents can enhance sensitivity of tumors to chemotherapy and radiotherapy. In addition to in vitro studies, as well as experiments on the different preclinical models have shown capacity of natural products in suppressing cancer stemness. Furthermore, use of nanostructures for improving therapeutic impact of dietary agents is recommended to rapidly translate preclinical findings for clinical use. Full article
Show Figures

Figure 1

50 pages, 8573 KiB  
Review
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by Ridhima Kaul, Pradipta Paul, Sanjay Kumar, Dietrich Büsselberg, Vivek Dhar Dwivedi and Ali Chaari
Int. J. Mol. Sci. 2021, 22(20), 11069; https://doi.org/10.3390/ijms222011069 - 14 Oct 2021
Cited by 56 | Viewed by 8747
Abstract
The ongoing COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a globally leading public health concern over the past two years. Despite the development and administration of multiple vaccines, the mutation of newer strains and challenges to universal [...] Read more.
The ongoing COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a globally leading public health concern over the past two years. Despite the development and administration of multiple vaccines, the mutation of newer strains and challenges to universal immunity has shifted the focus to the lack of efficacious drugs for therapeutic intervention for the disease. As with SARS-CoV, MERS-CoV, and other non-respiratory viruses, flavonoids present themselves as a promising therapeutic intervention given their success in silico, in vitro, in vivo, and more recently, in clinical studies. This review focuses on data from in vitro studies analyzing the effects of flavonoids on various key SARS-CoV-2 targets and presents an analysis of the structure-activity relationships for the same. From 27 primary papers, over 69 flavonoids were investigated for their activities against various SARS-CoV-2 targets, ranging from the promising 3C-like protease (3CLpro) to the less explored nucleocapsid (N) protein; the most promising were quercetin and myricetin derivatives, baicalein, baicalin, EGCG, and tannic acid. We further review promising in silico studies featuring activities of flavonoids against SARS-CoV-2 and list ongoing clinical studies involving the therapeutic potential of flavonoid-rich extracts in combination with synthetic drugs or other polyphenols and suggest prospects for the future of flavonoids against SARS-CoV-2. Full article
Show Figures

Figure 1

24 pages, 2388 KiB  
Review
Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment
by Yue Yang, Ning Li, Tian-Ming Wang and Lei Di
Int. J. Mol. Sci. 2021, 22(19), 10827; https://doi.org/10.3390/ijms221910827 - 07 Oct 2021
Cited by 31 | Viewed by 3883
Abstract
Lung cancer is one of the most prevalent malignancies worldwide. Despite the undeniable progress in lung cancer research made over the past decade, it is still the leading cause of cancer-related deaths and continues to challenge scientists and researchers engaged in searching for [...] Read more.
Lung cancer is one of the most prevalent malignancies worldwide. Despite the undeniable progress in lung cancer research made over the past decade, it is still the leading cause of cancer-related deaths and continues to challenge scientists and researchers engaged in searching for therapeutics and drugs. The tumor microenvironment (TME) is recognized as one of the major hallmarks of epithelial cancers, including the majority of lung cancers, and is associated with tumorigenesis, progression, invasion, and metastasis. Targeting of the TME has received increasing attention in recent years. Natural products have historically made substantial contributions to pharmacotherapy, especially for cancer. In this review, we emphasize the role of the TME and summarize the experimental proof demonstrating the antitumor effects and underlying mechanisms of natural products that target the TME. We also review the effects of natural products used in combination with anticancer agents. Moreover, we highlight nanotechnology and other materials used to enhance the effects of natural products. Overall, our hope is that this review of these natural products will encourage more thoughts and ideas on therapeutic development to benefit lung cancer patients. Full article
Show Figures

Figure 1

Back to TopTop